Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Extended Peginterferon Plus Ribavirin Treatment for 72 Weeks Versus Standard Peginterferon Plus Ribavirin Treatment for 48 Weeks in Chronic Hepatitis C Genotype 1 Infected Slow-responder Adult Patients: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439804/all/Extended_peginterferon_plus_ribavirin_treatment_for_72_weeks_versus_standard_peginterferon_plus_ribavirin_treatment_for_48_weeks_in_chronic_hepatitis_C_genotype_1_infected_slow_responder_adult_patients:_Cochrane_systematic_review. Accessed 20 April 2024.
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/all/Extended_peginterferon_plus_ribavirin_treatment_for_72_weeks_versus_standard_peginterferon_plus_ribavirin_treatment_for_48_weeks_in_chronic_hepatitis_C_genotype_1_infected_slow_responder_adult_patients:_Cochrane_systematic_review. Accessed April 20, 2024.
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/all/Extended_peginterferon_plus_ribavirin_treatment_for_72_weeks_versus_standard_peginterferon_plus_ribavirin_treatment_for_48_weeks_in_chronic_hepatitis_C_genotype_1_infected_slow_responder_adult_patients:_Cochrane_systematic_review
Extended Peginterferon Plus Ribavirin Treatment for 72 Weeks Versus Standard Peginterferon Plus Ribavirin Treatment for 48 Weeks in Chronic Hepatitis C Genotype 1 Infected Slow-responder Adult Patients: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/all/Extended_peginterferon_plus_ribavirin_treatment_for_72_weeks_versus_standard_peginterferon_plus_ribavirin_treatment_for_48_weeks_in_chronic_hepatitis_C_genotype_1_infected_slow_responder_adult_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review
ID - 439804
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/all/Extended_peginterferon_plus_ribavirin_treatment_for_72_weeks_versus_standard_peginterferon_plus_ribavirin_treatment_for_48_weeks_in_chronic_hepatitis_C_genotype_1_infected_slow_responder_adult_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -